Amgen Inc (NASDAQ: AMGN) has reported earnings for its third fiscal quarter (ending September 30) of $5.27 versus $3.23 for the same period a year ago — an increase of 63%. For the latest four quarters through September 30, E.P.S. were $7.88 compared to $14.14 a year ago — a decline of -44%.
Recent Price Action
Amgen Inc (NASDAQ: AMGN) stock closed at $315.54 on 10/30/24 after a slight decline of -0.1%. Moreover, trading volume in this decline was above average at 120% of normal. Relative to the market the stock has been strong over the last nine months but has declined -1.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, AMGN is expected to continue to be a major Value Builder.
Amgen has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Amgen has a slightly positive Power Rating of 68 and a good Appreciation Score of 84, and the Highest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment